Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811297
What this trial is testing
Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers
Who this might be right for
Endometrial NeoplasmsOvarian NeoplasmsSoft Tissue Sarcoma (STS)+1 more
Advenchen Pharmaceuticals, LLC. 138